Generation of carcinoembryonic antigen (CEA)-specific T-cell responses in HLA-A*0201 and HLA-A*2402 late-stage colorectal cancer patients after vaccination with dendritic cells loaded with CEA peptides
/in Colorectal Cancer, Dendritic Cells, International PublicationsDendritic cell-based combined immunotherapy with autologous tumor-pulsed dendritic cell vaccine and activated T cells for cancer patients: rationale, current progress, and perspectives
/in Colorectal Cancer, Dendritic Cells, International PublicationsDoxorubicin activity is enhanced by hyperthermia in a model of ex vivo vascular perfusion of human colon carcinoma
/in Colorectal Cancer, Hyperthermia, International PublicationsApplication of autologous tumor cell vaccine and NDV vaccine in treatment of tumors of digestive tract
/in Colorectal Cancer, International PublicationsHuman tumor cell infection by Newcastle Disease Virus leads to upregulation of HLA and cell adhesion molecules and to induction of interferons, chemokines and finally apoptosis
/in Breast Cancer, Colorectal Cancer, Glioblastoma, International Publications, Newcastle Disease VirusImmunotherapy of solid cancer using dendritic cells pulsed with the HLA-A24-restricted peptide of carcinoembryonic antigen
/in Colorectal Cancer, Dendritic Cells, International PublicationsEnhancement of the therapeutic outcome of radio-immunotherapy by combination with whole-body mild hyperthermia
/in Colorectal Cancer, Hyperthermia, International PublicationsAltered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy
/in Colorectal Cancer, Dendritic Cells, International PublicationsComparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group
/in Cervical Cancer, Colorectal Cancer, Hyperthermia, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de